These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 27738175)
1. Oral Administration of Pentoxifylline Reduces Endometriosis-Like Lesions in a Nude Mouse Model. Perelló M; González-Foruria I; Castillo P; Martínez-Florensa M; Lozano F; Balasch J; Carmona F Reprod Sci; 2017 Jun; 24(6):911-918. PubMed ID: 27738175 [TBL] [Abstract][Full Text] [Related]
2. Natural therapies assessment for the treatment of endometriosis. Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of pentoxifylline on white blood cell count in serum and peritoneal fluid in female rats with endometriosis. Mohammadzadeh A; Heidari M; Soltanghoraee H; Jeddi-Tehrani M; Ghaffari Novin M; Akhondi MM; Zeraati H; Mohammadzadeh F J Obstet Gynaecol Res; 2008 Jun; 34(3):307-13. PubMed ID: 18686342 [TBL] [Abstract][Full Text] [Related]
4. Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model. Vlahos NF; Gregoriou O; Deliveliotou A; Perrea D; Vlachos A; Zhao Y; Lai J; Creatsas G Fertil Steril; 2010 Mar; 93(4):1316-23. PubMed ID: 19147132 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Rudzitis-Auth J; Menger MD; Laschke MW Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233 [TBL] [Abstract][Full Text] [Related]
6. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model. Ozcan Cenksoy P; Oktem M; Erdem O; Karakaya C; Cenksoy C; Erdem A; Guner H; Karabacak O Gynecol Endocrinol; 2015 Mar; 31(3):219-24. PubMed ID: 25373440 [TBL] [Abstract][Full Text] [Related]
7. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model. Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway. Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979 [TBL] [Abstract][Full Text] [Related]
9. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995 [TBL] [Abstract][Full Text] [Related]
10. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions. Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472 [TBL] [Abstract][Full Text] [Related]
12. Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hull ML; Prentice A; Wang DY; Butt RP; Phillips SC; Smith SK; Charnock-Jones DS Hum Reprod; 2005 Feb; 20(2):350-8. PubMed ID: 15567877 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis. García-Pascual CM; Martínez J; Calvo P; Ferrero H; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Pellicer A; Gómez R Fertil Steril; 2015 Nov; 104(5):1310-8. PubMed ID: 26297642 [TBL] [Abstract][Full Text] [Related]
14. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695 [TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. Kamencic H; Thiel JA J Minim Invasive Gynecol; 2008; 15(1):62-6. PubMed ID: 18262146 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model. Nakamura DS; Edwards AK; Virani S; Thomas R; Tayade C Am J Pathol; 2012 Aug; 181(2):570-82. PubMed ID: 22727957 [TBL] [Abstract][Full Text] [Related]
17. Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: a paradigm for a novel approach to the treatment of endometriosis-associated subfertility. Steinleitner A; Lambert H; Roy S Fertil Steril; 1991 Jan; 55(1):26-31. PubMed ID: 1986967 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis. Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036 [TBL] [Abstract][Full Text] [Related]
19. Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Güney M; Oral B; Karahan N; Mungan T Fertil Steril; 2008 Apr; 89(4):934-42. PubMed ID: 17582405 [TBL] [Abstract][Full Text] [Related]
20. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model. Quattrone F; Sanchez AM; Pannese M; Hemmerle T; Viganò P; Candiani M; Petraglia F; Neri D; Panina-Bordignon P Reprod Sci; 2015 Sep; 22(9):1143-52. PubMed ID: 25850899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]